1. Bani, D., Failli, P. and Grazia Bello, M. (1998) Relaxin activates the l-arginine-nitric oxide pathway in vascular smooth muscle cells in culture. Hypertension, 31, 1240–1247.
2. Bell, R.J., Permezel, M. and MacLennan, A. (1993) A randomized, double-blind, placebo-controlled trial of the safety of vaginal recombinant human relaxin for cervical ripening. Obstet. Gynecol., 82, 328–333.
3. Bigazzi, M., Del Mese, M.A., Petrucci F. et al. (1986) The local administration of relaxin induces changes in the microcirculation of the rat mesocaecum. Acta Endocrinol., 119, 149–154.
4. Bryant-Greenwood, G.D., Bogic, L., Maaskant, R. et al. (1994) Decidual relaxin and the human fetal membranes. In Tregear, G., MacLennan, A.H., Bryant-Greenwood, G.D. (eds), Progress in Relaxin Research. Global Publications Service, Singapore, pp. 298–305.
5. Churchill, D. and Beevers, D.G. (1999) Hypertension in Pregnancy. BMJ Books, London.